DurgicalDurgical
EN
Open the app

Acamprosate !

A medicine that helps people who have stopped drinking stay abstinent. It is not metabolised and leaves through the kidneys, so it suits liver disease.

Updated 2026-11-01

Mechanism of action

Long-term drinking leaves the brain with too much glutamate excitation and too little GABA inhibition once alcohol stops, which feeds craving. Acamprosate (N-acetylhomotaurine) is thought to rebalance these two systems; its exact mechanism is not known.

  1. After stopping alcohol, glutamate excitation runs high
  2. Acamprosate helps rebalance glutamate and GABA
  3. Craving falls and abstinence is easier to keep

Pharmacokinetics

Absorption
Low bioavailability by mouth, about 11%
Metabolism
Not metabolised
Elimination
Unchanged through the kidneys
Half-life
About 20 to 33 hours (terminal)

Indications

  • Keeping abstinence in alcohol dependence, in people already abstinent, with psychosocial support Alcohol use disorder →

Adverse effects

Common

  • Diarrhoea (the most frequent)
  • Insomnia and weakness
  • Itching, nausea and flatulence

Contraindications

  • Severe kidney impairment
  • Hypersensitivity to acamprosate

Key interactions

Naltrexone
Modestly higher acamprosate levels; not clinically important
Alcohol, disulfiram, diazepam
Do not change acamprosate kinetics

What is monitored

  • Kidney function (creatinine clearance) before and during treatment
  • Mood and suicidal thoughts
  • Drinking and relapse

Administration and safety

  • Given by mouth as delayed-release tablets, with or without food
  • Started after alcohol withdrawal is over, as part of a support programme
  • Continued even if a relapse occurs

Nursing care

  • Check kidney function before the first dose
  • Ask about mood and thoughts of self-harm at each visit
  • Teach that it does not stop withdrawal symptoms or cause a reaction with alcohol
  • Encourage counselling or support groups

Pregnancy and breastfeeding

Used in pregnancy only if the benefit justifies the risk; animal studies showed malformations.

Test yourself

Think of the answer, then tap the question to see it.

Why is acamprosate a good option in alcoholic liver disease?

It is not metabolised by the liver and is excreted unchanged in the urine.

When is acamprosate started?

Once the person is abstinent; it does not relieve withdrawal.

What is the most frequent adverse effect of acamprosate?

Diarrhoea.

Add to my cards (3)

← Back to the class: Medicines for alcohol use disorder

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - ACAMPROSATE CALCIUM tablet, delayed release (DailyMed (U.S. National Library of Medicine), 2026); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 27 (McGraw Hill, 2023); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.